Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Putting Ovarian Self-Awareness in Action with Bright Pink

September 6th 2017, 8:46pm

Article

September is Ovarian Cancer Awareness Month, but many people still aren’t aware of the symptoms and risk factors that can sometimes lead to an ovarian cancer diagnosis. Here are two steps you can take to personalize your approach to ovarian health management by being "ovarian self-aware."

Finding More Molecular Targets for Ovarian Cancer to Personalize Treatment

September 5th 2017, 7:54pm

Article

In a recent study, researchers were working on identifying different molecular targets to better provide personalized care to patients with ovarian cancer. To do this, they examined more than 4,000 tumor specimins.

BRCA Mutations May Cause Drug Resistance in Breast and Ovarian Cancer

September 4th 2017, 9:36pm

Article

There is a relationship between the genetics of BRCA1 and BRCA2 mutations and the risk of a patient with breast or ovarian cancer being resistant to platinum-based chemotherapy, according to recent research conducted at the Perelman School of Medicine at the University of Pennsylvania. The study’s senior author Katherine Nathanson, M.D., spoke with CURE about these findings.

Five Ways to Reduce Your Risk of Breast and Ovarian Cancer

August 25th 2017, 11:30pm

Article

How to Assess Your Risk of Breast or Ovarian Cancer

August 24th 2017, 11:39pm

Video

J&J Ordered to pay $417 Million in Ovarian Cancer Case

August 23rd 2017, 10:21pm

Article

Another case has been settled regarding Johnson & Johnson's Baby Powder and its possible link to ovarian cancer.

Learn to Speak Cancer's Foreign Language

August 21st 2017, 9:00am

Article

Cancer treatment may seem to involve a mysterious, unfathomable foreign language, but there are ways to improve those lines of communication.

Maintenance Lynparza Tablets Approved in Ovarian Cancer

August 17th 2017, 10:31pm

Article

Lynparza tablets (olaparib) tablets were granted FDA approval as a maintenance therapy for patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.

Dr. Boulay Discusses Removing a 140-Pound Tumor

August 15th 2017, 11:10pm

Video

Richard Boulay, M.D., chief of the division of Gynecologic Oncology at the Lehigh Valley Health Netowrk, tells the story of removing a 140-pound tumor from Mary Clancy. The tumor had been growing for at least 10 years when it was caught by a CAT scan, and was about half her body weight.

A Promising New Agent for Epithelial Ovarian Cancer

August 15th 2017, 6:33pm

Article

A new agent showed a favorable toxicity profile for patients with epithelial ovarian cancer. The drug, mirvetuximab soravtansine (IMGN853), also demonstrated encouraging clinical activity in a phase 1 trial presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.